Controlling impurities is foundational to the safe and effective development of antibody-drug conjugates.
By integrating advanced techniques, Samsung Biologics provides a robust impurity control platform that supports high drug-to-antibody ratio precision, accurate free drug quantification, and reliable residual solvent detection. These capabilities not only mitigate risk and enhance product quality, but also enable efficient, scalable development that keeps pace with regulatory expectations and accelerates the path to market.
Controlling impurities is foundational to the safe and effective development of antibody-drug conjugates.
By integrating advanced techniques, Samsung Biologics provides a robust impurity control platform that supports high drug-to-antibody ratio precision, accurate free drug quantification, and reliable residual solvent detection. These capabilities not only mitigate risk and enhance product quality, but also enable efficient, scalable development that keeps pace with regulatory expectations and accelerates the path to market.
- CDO
- CGMP
- ADC
- Bio Campus
- IR
- CMO